01-07-2022 | Shock | Case report
Angiotensin-II/vasopressin
Various toxicities, lack of efficacy and off-label use: 8 case reports
Published in: Reactions Weekly | Issue 1/2022
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event